A Study of a Mastoid Device in Subjects With Ménière's Disease
NCT03520322 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2024-12-12
Summary
The purpose of this study is to investigate the efficacy of a mastoid treatment device in patients with active Ménière's disease that is not controlled by traditional medical management
Conditions
- Meniere Disease
Interventions
- DEVICE
-
Mastoid Oscillator
The oscillator will be placed over the mastoid of their involved ear and secured via an elastic/Velcro headband. The subject is positioned so as to place the endolymphatic duct into a gravitationally dependent orientation (the subject lying on their contralateral side with the face slightly tilted towards the floor). The device is turned on and operated for 30 minutes.
- DEVICE
-
Control Device
The control device will be placed over the mastoid of their involved ear and secured via an elastic/Velcro headband. The subject is positioned so as to place the endolymphatic duct into a gravitationally dependent orientation (the subject lying on their contralateral side with the face slightly tilted towards the floor). The device is turned on and operated for 30 minutes.
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-29
- Primary Completion
- 2024-02-14
- Completion
- 2024-12-04
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Local Overpressure Treatment for Meniere's Disease
NCT00831688 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02706730 ·Status: TERMINATED ·Phase: PHASE3
-
Latanoprost for the Treatment of Menière's Disease
NCT01973114 ·Status: UNKNOWN ·Phase: PHASE2
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02768662 ·Status: TERMINATED ·Phase: PHASE3
-
Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
NCT00802529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis
NCT03399721 ·Status: COMPLETED ·Phase: NA
-
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
NCT06001593 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
NCT02080312 ·Status: COMPLETED ·Phase: NA
-
A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom
NCT02265393 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Lamotrigine to Treat Ménière's Disease
NCT02158585 ·Status: COMPLETED ·Phase: PHASE2
-
SPI-1005 for the Treatment of Meniere's Disease
NCT04677972 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere's Disease
NCT03215420 ·Status: COMPLETED ·Phase: NA
-
Acceleration of the Kinetics of Diffusion of Gadolinium in the Perilymphatic Structures of the Inner Ear.
NCT04949321 ·Status: UNKNOWN ·Phase: NA
-
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
NCT04806282 ·Status: RECRUITING
-
Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
NCT05355610 ·Status: UNKNOWN ·Phase: NA
-
Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss
NCT02105441 ·Status: COMPLETED
-
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508 ·Status: RECRUITING ·Phase: PHASE3
-
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214 ·Status: COMPLETED ·Phase: PHASE2
-
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
NCT04815187 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
CI Following VS Removal or Labyrinthectomy
NCT03795675 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
NCT04674735 ·Status: WITHDRAWN ·Phase: PHASE1
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Endolymphatic Sac Drainage With Steroids for Meniere's Disease
NCT00500474 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
NCT06765993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3